Maglasang, Judelyn S.
HRN: 15-02-81 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/14/2024
CO-AMOXICLAV 625MG (TAB)
03/14/2024
03/20/2024
PO
625mg
BID
S/P RMLE
Waiting Final Action